Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology

We aimed to explore the molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer (TNBC) by using network pharmacology. The active components and targets of the prescription were obtained by Traditional Chinese medicine systems pharmacology database. Gencard...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Meiling, Meng, Tian, Zhou, Yue, Jin, Lan, Dai, Qiuying, Ma, Lina, Chen, Hongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476815/
https://www.ncbi.nlm.nih.gov/pubmed/37657065
http://dx.doi.org/10.1097/MD.0000000000034763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476815/
https://www.ncbi.nlm.nih.gov/pubmed/37657065
http://dx.doi.org/10.1097/MD.0000000000034763

Ejemplares similares